One potential mechanism underlying the histological transition from EGFR-mutant NSCLC to SCLC is lineage plasticity, which enables the dedifferentiation of cancer cells from an epithelial to a neuroendocrine lineage in response to EGFR-TKI treatment (24). The gene discussed is EGFR; the disease is small cell lung carcinoma.